Annuncio • Apr 29
eHealth, Inc., Annual General Meeting, Jun 18, 2026 eHealth, Inc., Annual General Meeting, Jun 18, 2026. Annuncio • Apr 23
eHealth, Inc. to Report Q1, 2026 Results on May 06, 2026 eHealth, Inc. announced that they will report Q1, 2026 results on May 06, 2026 Annuncio • Apr 17
eHealth Announces Final Expense Life Insurance Plans eHealth had announced it now offers Final Expense life insurance plans, helping Americans and their families prepare for funeral and burial or cremation expenses. The new plans are part of eHealth's strategy to better meet the coverage and wellness needs of individuals and families, offering an expanded portfolio of plans, services and support to help consumers live healthier, more financially secure lives. A new eHealth survey of over 1,000 Americans aged 65 and older found many people are unprepared to cover end-of-life expenses. Key survey findings include: 69% underestimate the average cost of a funeral with viewing and cremation, while 35% underestimate the average cost of a funeral with burial. 62% plan to be cremated, while 23% prefer to be buried; 15% don't know or have no preference. 47% worry about burdening loved ones with the cost of a funeral and burial or cremation. Among survey respondents living on an income of less than $50,000 per year: 56% worry about burdening their loved ones with the cost of a funeral and burial or cremation. 33% have no insurance or money set aside to help cover these end-of-life expenses. EHealth's Final Expense plans are offered through Mutual of Omaha and available by phone, allowing licensed insurance agents to address coverage options as part of a broader, personalized financial protection discussion. The policies can provide tax-free funds for various purposes, including funeral and burial or cremation expenses, outstanding medical bills, travel costs, legal fees, or other related needs. Two types of Final Expense plans are available: Level Benefit Plans, offered to people ages 45 to 85, with coverage amounts ranging from $2,000 to $50,000. Graded Benefit Plans, offered to people ages 45 to 80, with coverage amounts ranging from $2,000 to $20,000. Applicants are not required to undergo a medical exam to qualify for coverage. Instead, eligibility is determined through responses to a limited set of health questions covering a lookback period of approximately two to four years. The plans are designed to be affordable and provide beneficiaries with quick access to guaranteed funds, helping reduce financial stress during a difficult time. The average cost of a funeral with a viewing and burial exceeds $8,000, while the average cost of a funeral with a viewing and cremation is more than $6,000. Specific plan availability may vary by state; some plans may not be available in Arkansas, Montana, New York, and North Carolina. Coverage and premiums may vary based on qualifying factors. Annuncio • Apr 01
Andrea Brimmer to Step Down from Board of Directors of eHealth, Inc. on June 18, 2026 eHealth, Inc. announced that Andrea Brimmer will not stand for re-election to the Company's Board of Directors and will step down when her current term expires at the Company's next annual meeting of shareholders to be held on June 18, 2026. Ms. Brimmer will continue to serve as a member of the Board until the expiration of her term at the Company's upcoming annual meeting. Annuncio • Feb 10
eHealth, Inc. to Report Q4, 2025 Results on Feb 25, 2026 eHealth, Inc. announced that they will report Q4, 2025 results on Feb 25, 2026 Annuncio • Dec 18
eHealth, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025 eHealth, Inc. revised earnings guidance for the year ending December 31, 2025. For the year ending December 31, 2025, the company expects total revenue is expected to be in the range of $540.0 million to $560.0 million, compared to the prior range of $525.0 million to $565.0 million. GAAP net income is expected to be in the range of $30 million to $45 million, compared to the prior range of $9.0 million to $30.0 million. Annuncio • Nov 12
eHealth Advances its AI Strategy with Expanded Voice Agent Capabilities eHealth announced the expanded use of Alice, its AI-powered voice agent. Alice has expanded beyond its initial use for shopping and initial enrollment telephone support and is now assisting with post-enrollment and general service calls from Medicare Advantage beneficiaries, helping to efficiently address and resolve common inquiries such as: Application status: Alice provides customers with general information on their application status as provided by the health plan. Soon, she will also be able to look up specific details and inform callers exactly where their application is with the health plan in the process. ID card inquiries: Alice informs customers when they generally can expect to receive their insurance ID cards and, if necessary, directs them to contact their health plan for further assistance. Billing questions: Alice provides customers with direct billing contact phone numbers for their respective health plan, making it easier for individuals to access assistance when billing support is required. Do Not Call requests: Alice can initiate steps to remove customers from eHealth's call list upon request, ensuring their communication preferences are respected. eHealth's leadership in technology has defined the company since its founding. Today, eHealth has distinguished itself from other Medicare brokers by deploying leading AI technology at scale, continuing its commitment to improving the customer experience. The expansion of Alice marks another step forward in eHealth's mission to use technology to make healthcare simpler and more accessible for everyone. Alice already handles all after-hours Medicare Advantage inquiries and supports both initial enrollment assistance and service calls during business hours when agents are unavailable. In the future, eHealth plans to extend Alice's capabilities to assist individuals with shopping for other types of health insurance plans. For years, eHealth has leveraged AI and machine learning to match beneficiaries with the most suitable health plans based on their unique needs, including coverage requirements, physicians, and prescription drugs, from a broad catalog of leading national and regional insurers. To experience Alice in action, listen to this demo. Annuncio • Oct 31
eHealth, Inc. to Report Q3, 2025 Results on Nov 05, 2025 eHealth, Inc. announced that they will report Q3, 2025 results on Nov 05, 2025 Annuncio • Oct 01
eHealth, Inc. Releases Findings from New Survey eHealth, Inc. released findings from a new survey showing most Medicare beneficiaries find it confusing to shop for a plan during the Annual Enrollment Period (AEP), with about one-third of Medicare Advantage enrollees largely unaware of significant changes expected for the coming year. The survey of more than 1,500 Medicare beneficiaries offers timely insights as millions of Americans will soon make coverage decisions during this year's AEP, which runs from Oct. 15 through Dec. 7, 2025. Key findings from eHealth's survey include: 75% of Medicare beneficiaries said choosing a Medicare plan is confusing. 51% of Medicare beneficiaries intend to review their coverage options this AEP, compared to 63% who said they did so last year. 36% of Medicare Advantage and Part D plan enrollees said they are unaware that significant cost and benefit changes are expected for 2026. 33% of Medicare beneficiaries agree they don't have a good understanding of how Medicare Advantage, Medicare Supplement, and Part D plans differ. 33% of Medicare beneficiaries incorrectly believe Medicare covers GLP-1 drugs for weight loss. 29% of Medicare beneficiaries are unaware that Medicare covers recommended vaccines with no out-of-pocket costs. Annuncio • Sep 20
eHealth, Inc Announces Board and Committee Changes On September 17, 2025, Aaron Tolson notified the Board of Directors of eHealth, Inc. he is resigning from the Board, as well as from the Board’s compensation committee, nominating and corporate governance committee and government and regulatory affairs committee, effective immediately. Mr. Tolson was initially appointed to the Board as a designee of Echelon Health SPV, LP pursuant to the terms of the Investment Agreement, dated February 17, 2021, by and between the Company and H.I.G. The resignation of Mr. Tolson was not the result of any disagreement between Mr. Tolson and the Company. On September 17, 2025, the Board appointed Todd Arden as a member of the Board, effective immediately. Mr. Arden was appointed to the Board as a designee of H.I.G. pursuant to the Investment Agreement and to fill the vacancy created by Mr. Tolson’s resignation. Mr. Arden will serve as a Class I director, with a term expiring at the Company’s 2028 annual meeting of stockholders. Mr. Arden was also appointed to the Board’s Compensation Committee, Nominating Committee and Government and Regulatory Affairs Committee. On September 18, 2025, the Board increased the number of directors of the Company from nine to ten and appointed Derrick Duke to serve as a Class I director of the Board, effective immediately, with a term expiring at the Company’s 2028 annual meeting of stockholders. No arrangement or understanding exists between Derrick Duke and any other person pursuant to which he was appointed as a director. Annuncio • Jul 29
eHealth, Inc. Announces CEO Changes eHealth, Inc. announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4, 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on the Board. Soistman will remain with the Company as an executive advisor through December 31, 2025, to assist with the transition. Derrick Duke currently serves as CEO of Magellan Health, a leading national healthcare management organization and subsidiary of Centene Corporation. Previously, he held senior leadership roles at Magellan, including the dual roles of Chief Operating and Chief Financial Officer where he led the finance organization, business transformation initiatives, and behavioral health clinical services. Derrick Duke brings over 30 years of strategic leadership and financial expertise in the health insurance and managed care sectors. Most recently, he served as Chief Executive Officer at Magellan Health, a leading national healthcare management firm, where he led strategic growth and operational execution following a rapid rise through the C-suite – first as Chief Risk Officer in 2020, and then as Chief Operating and Financial Officer in early 2022.Before joining Magellan, Derrick spent nearly 16 years at Health Markets, one of the largest U.S. health insurance agencies, holding multiple senior roles including Chief Investment Officer, Chief Financial Officer, and Chief Operating Officer. He steered the company's finance, actuarial, IT, underwriting, compliance and customer service teams and helped lead the organization through its acquisition by UnitedHealth Group in 2019. Earlier in his career, Derrick was Executive Vice President and Chief Investment Officer at National Health Insurance (now part of Allstate Insurance), where he gained deep experience in investment strategy and insurer financial management. Derrick holds a bachelor's degree in finance from Hardin-Simmons University and an MBA from the University of Texas at Arlington. Annuncio • Jul 24
eHealth, Inc. to Report Q2, 2025 Results on Aug 06, 2025 eHealth, Inc. announced that they will report Q2, 2025 results on Aug 06, 2025 Annuncio • Apr 30
eHealth, Inc. Introduces AI Voice Agents to Enhance Customer Experience in Health Plan Selection eHealth, Inc. unveiled a new AI-based voice, non-licensed agent designed to streamline the health insurance plan selection process. This launch marks a significant milestone in eHealth's ongoing, multi-year strategy to leverage AI empathetically, enhancing the expertise of licensed insurance agents to provide an exceptional consumer experience. The AI-based voice agents started by handling incoming Medicare calls to eHealth during after-hours, reducing the wait time for consumers who may otherwise need to wait longer to speak with a human screener. The AI-powered voice agents can enhance the customer experience by initiating the customer intake process, gathering personal information, checking initial eligibility, and communicating necessary disclosures. Since launching as a pilot earlier in 2025, among callers served by the AI agents, the program has: Eliminated after-hours wait times and ensured a 100% answer rate. Nearly doubled the percentage of callers (18.5% compared to 34.5%) who expressed interest in purchasing a plan, as compared to human screeners. The AI-based agents have expanded from initially handling after-hours calls to now assisting with incoming Medicare calls during business hours on a pilot basis. In the future, the AI agents are expected to serve people calling eHealth shopping for other types of insurance plans. In addition, a recent eHealth survey of over 500 consumers found significant interest in the use of AI to improve the experience when calling customer service. Among the findings from the survey regarding customer service in general: 74% are willing to answer a few questions from an AI assistant if it means getting faster and better help later in the process. 56% agree that working with an AI assistant can provide them with faster, more accurate help. 66% said long hold times are the biggest frustration when calling customer service, followed by difficulty reaching a real person (59%) and poorly trained agents (42%). Key features of the new eHealth AI-based voice agents: Streamlined information gathering. Using a conversational approach, the AI-based voice agents gather key details, including personal information, initial eligibility, and plan preferences. By streamlining the process, the AI agents can eliminate wait times and reduce the effort required for callers to shop for health benefits, making the plan selection process more accessible for everyone. Enhanced accuracy and cost efficiency. Using advanced algorithms and voice-recognition technology, the AI agents help minimize errors and ensure callers are matched with an appropriate licensed insurance agent to then review appropriate plan options based on location, health care goals and budget. Compared to human screeners, the AI agents are more cost efficient. User-friendly and consistent service: The intuitive experience of the AI-based voice agents enables users to provide initial information more easily and start the plan selection experience, while expediting the process once the caller is connected to a live, licensed insurance agent. The AI agents are designed to answer all customer questions with empathy and patience, with feedback from callers emphasizing feelings of being respected and valued. Annuncio • Apr 29
eHealth, Inc., Annual General Meeting, Jun 18, 2025 eHealth, Inc., Annual General Meeting, Jun 18, 2025. Annuncio • Apr 24
eHealth, Inc. to Report Q1, 2025 Results on May 07, 2025 eHealth, Inc. announced that they will report Q1, 2025 results at 12:30 PM, US Eastern Standard Time on May 07, 2025 Annuncio • Mar 01
Ehealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2025 eHealth, Inc. provided earnings guidance for the full year ending December 31, 2025. For the year, the company expects Total revenue is expected to be in the range of $510.0 million to $550.0 million. GAAP net income (loss) is expected to be in the range of $(10.0) million to $15.0 million. Annuncio • Feb 13
eHealth, Inc. to Report Q4, 2024 Results on Feb 26, 2025 eHealth, Inc. announced that they will report Q4, 2024 results on Feb 26, 2025 Annuncio • Jan 29
"Iris by eHealth" ICHRA Solution Makes Employer Health Benefits Affordable with Personalized Coverage for Employees eHealth, Inc. announced the launch of Iris by eHealth, an end-to-end Individual Coverage Health Reimbursement Account (ICHRA) solution for employers who want to support employee healthcare but struggle with the unpredictable costs of group health plans. Here's how Iris by eHealth works: The employer determines a flat monthly contribution to be made toward each employee's health coverage, Using eHealth's Iris platform, employees select their own plan from among top insurance companies in their area, By adding their preferred doctors and prescriptions, they can narrow down their choices to those best suited to their personal needs, eHealth's proven customer care team manages enrollments and provides direct support to employees, Once enrolled, the employer's monthly contribution funds some, or all, of the employee's health insurance premiums. There are no plan markups or hidden fees with Iris. eHealth's licensed agents are available nationwide by phone or chat to help employers and their employees find the coverage they need, with a free annual review of plan options. Annuncio • Dec 18
eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2024 eHealth, Inc. revised earnings guidance for the full year ending December 31, 2024. Total revenue is expected to be in the range of $500.0 million to $520.0 million compared to the prior range of $470.0 million to $495.0 million. GAAP net income (loss) is expected to be in the range of $(12.0) million to $3.0 million compared to the prior range of $(36.5) million to $(22.0) million. Recent Insider Transactions • Nov 15
Independent Director recently sold €98k worth of stock On the 11th of November, Dale Wolf sold around 20k shares on-market at roughly €4.92 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought €229k more than they sold in the last 12 months. Reported Earnings • Nov 07
Third quarter 2024 earnings released: US$1.83 loss per share (vs US$1.68 loss in 3Q 2023) Third quarter 2024 results: US$1.83 loss per share (further deteriorated from US$1.68 loss in 3Q 2023). Revenue: US$58.4m (down 9.7% from 3Q 2023). Net loss: US$53.9m (loss widened 14% from 3Q 2023). Revenue is forecast to grow 8.3% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings. Annuncio • Oct 23
eHealth, Inc. to Report Q3, 2024 Results on Nov 06, 2024 eHealth, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024 Board Change • Sep 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. CEO & Director Fran Soistman was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Aug 11
CEO & Director recently bought €187k worth of stock On the 8th of August, Francis Soistman bought around 50k shares on-market at roughly €3.73 per share. This transaction amounted to 10% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Francis' only on-market trade for the last 12 months. Reported Earnings • Aug 08
Second quarter 2024 earnings released: US$1.33 loss per share (vs US$1.18 loss in 2Q 2023) Second quarter 2024 results: US$1.33 loss per share (further deteriorated from US$1.18 loss in 2Q 2023). Revenue: US$65.9m (down 1.4% from 2Q 2023). Net loss: US$39.0m (loss widened 19% from 2Q 2023). Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings. Annuncio • Aug 07
eHealth, Inc. Announces Retirement of Fran Soistman as Chief Executive Officer eHealth, Inc. announced that Fran Soistman will retire from his role as Chief Executive Officer upon the appointment of a successor, which is expected to occur by or before the second quarter of 2025. Following his retirement as CEO, Mr. Soistman intends to remain a director on the Company's Board of Directors. Mr. Soistman will support the new CEO to ensure a seamless transition. The Board has commenced a search for Mr. Soistman's successor and has engaged Spencer Stuart, to identify and evaluate both internal and external candidates. Annuncio • Jul 23
eHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024 eHealth, Inc. announced that they will report Q2, 2024 results on Aug 07, 2024 Reported Earnings • May 08
First quarter 2024 earnings released: US$0.96 loss per share (vs US$1.01 loss in 1Q 2023) First quarter 2024 results: US$0.96 loss per share (improved from US$1.01 loss in 1Q 2023). Revenue: US$93.0m (up 26% from 1Q 2023). Net loss: US$27.7m (loss narrowed 1.2% from 1Q 2023). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 56% per year, which means it is performing significantly worse than earnings. Annuncio • May 08
eHealth, Inc. Reiterate Earnings Guidance for the Full Year Ending December 31, 2024 eHealth, Inc. reiterated earnings guidance for the full year ending December 31, 2024. For the year, the company total revenue is expected to be in the range of $450 million to $475 million and GAAP net loss is expected to be in the range of $40 million to $20 million. New Risk • Apr 11
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 3.0% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings are forecast to decline by an average of 3.0% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$68m net loss in 2 years). Shareholders have been diluted in the past year (4.8% increase in shares outstanding). Annuncio • Feb 29
eHealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2024 eHealth, Inc. provided earnings guidance for the full year ending December 31, 2024. For the year, company expects Total revenue to be in the range of $450 million to $475 million and GAAP net income (loss) is expected to be in the range of $(40) million to $(20) million. New Risk • Feb 28
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: US$67m Forecast net loss in 3 years: US$14m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$14m net loss in 3 years). Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Reported Earnings • Feb 28
Full year 2023 earnings released: US$2.37 loss per share (vs US$4.37 loss in FY 2022) Full year 2023 results: US$2.37 loss per share (improved from US$4.37 loss in FY 2022). Revenue: US$452.9m (up 12% from FY 2022). Net loss: US$66.5m (loss narrowed 44% from FY 2022). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, earnings per share has fallen by 47% per year whereas the company’s share price has fallen by 48% per year. Annuncio • Feb 27
Ehealth, Inc. Unveils "Advisor in the Room" Pilot Program, Bridging the Gap Between Phone and In-Person Support eHealth, Inc. announced a new pilot program – ‘Advisor in the Room’ – that will transform a traditional phone call into a dynamic, visual experience. This innovative technology will empower eHealth's benefit advisors, who are licensed insurance agents, to instantly appear on a customer's computer or phone screen upon request, fostering a deeper connection and personalized support. How it works: During a phone call, advisors can seamlessly send a secure link to the customer. With a single click, the customer grants permission, and the advisor appears on their screen using secure video technology. This shared visual workspace enables: Transparent plan selection: Advisors can visually guide customers through health plans, plan benefits, and help them select a plan that would meet their needs. Enhanced personal connection: Seeing the advisor fosters trust and understanding, leading to a more positive customer experience. Increased efficiency: Visual communication clarifies explanations, reducing call times and ultimately leading to stronger conversions and better retention. Customer privacy: Customers will be able to maintain their privacy because they will not be visible to the advisor. eHealth's Advisor in the Room technology is expected to roll out for Medicare beneficiaries on a limited basis in Second Quarter 2024, with the goal of making it more broadly available to eHealth customers before Medicare's Annual Enrollment Period in the fall. Annuncio • Feb 16
eHealth, Inc. to Report Q4, 2023 Results on Feb 27, 2024 eHealth, Inc. announced that they will report Q4, 2023 results on Feb 27, 2024 New Risk • Jan 26
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Annuncio • Nov 21
eHealth, Inc. Announces Executive Changes eHealth, Inc. announced senior leadership changes. Chief Operating Officer and Chief Transformation Officer, Roman Rariy, will depart eHealth at the end of the year after nearly two years of service. Mr. Rariy will be taking on a new role as Chief Executive Officer at a manufacturing company. Chief Marketing Officer, Michelle Barbeau, has been appointed Chief Revenue Officer effective January 1, 2024 and will assume the responsibility for Sales, in addition to her Marketing responsibilities, in the newly formed Revenue Organization. Reported Earnings • Nov 10
Third quarter 2023 earnings released: US$1.68 loss per share (vs US$1.72 loss in 3Q 2022) Third quarter 2023 results: US$1.68 loss per share. Revenue: US$64.7m (up 21% from 3Q 2022). Net loss: US$47.2m (flat on 3Q 2022). Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Insurance industry in Germany. Annuncio • Nov 10
eHealth, Inc. Provides Earnings Guidance of the Year Ending December 31, 2023 eHealth, Inc. provided earnings guidance of the year ending December 31, 2023. For the period, the company expects total revenue to be in the range of $439 million to $459 million and GAAP net loss is expected to be in the range of $46 million to $26 million. Annuncio • Oct 26
eHealth, Inc. to Report Q3, 2023 Results on Nov 08, 2023 eHealth, Inc. announced that they will report Q3, 2023 results on Nov 08, 2023 Annuncio • Oct 12
Al Redmer Jr. Joins eHealth's Public Policy Advisory Committee eHealth, Inc. announced that Al Redmer Jr. has joined its Public Policy Advisory Committee, a panel of distinguished experts gathered to inform the company, the public, and policymakers on ideas for improving health care practices in both the public and private sectors. Mr. Redmer twice served as the Maryland Insurance Commissioner, from 2003 to 2005 and again from 2015 to 2020. During his tenure he also served as Chair of the National Association of Insurance Commissioners'Health Insurance and Managed Care Committee. From 1991 to 2003 Mr. Redmer was a Member of the Maryland House of Delegates. Mr. Redmer also served as CEO of Coventry Healthcare of Delaware. Other current members of eHealth's Public Policy Advisory Committee include Steve Beshear, former Governor of Kentucky; Jerome Adams, MD, former Surgeon General of the United States; Bobby Jindal, former Governor of Louisiana; Susan Kennedy, who served as Chief of Staff to former California Governor Arnold Schwarzenegger; and Woodrow "Woody" Myers, MD, former Health Commissioner of New York City and of the state of Indiana. Recent Insider Transactions • Sep 21
Independent Chairman of the Board recently bought €99k worth of stock On the 15th of September, Dale Wolf bought around 15k shares on-market at roughly €6.60 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Dale has been a buyer over the last 12 months, purchasing a net total of €161k worth in shares. New Risk • Aug 10
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$9.0m net loss in 3 years). Shareholders have been diluted in the past year (3.1% increase in shares outstanding). Reported Earnings • Aug 09
Second quarter 2023 earnings released: US$1.18 loss per share (vs US$1.65 loss in 2Q 2022) Second quarter 2023 results: US$1.18 loss per share (improved from US$1.65 loss in 2Q 2022). Revenue: US$66.8m (up 33% from 2Q 2022). Net loss: US$32.9m (loss narrowed 27% from 2Q 2022). Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 36 percentage points per year, which is a significant difference in performance. Annuncio • Aug 09
eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023 eHealth, Inc. revised earnings guidance for the full year ending December 31, 2023. Total revenue is expected to be in the range of $439 million to $459 million compared to prior guidance of $420 million to $440 million. GAAP net loss is expected to be in the range of $46 million to $26 million compared to prior guidance of $55 million to $35 million. Annuncio • Jul 26
eHealth, Inc. to Report Q2, 2023 Results on Aug 08, 2023 eHealth, Inc. announced that they will report Q2, 2023 results on Aug 08, 2023 Recent Insider Transactions • Jun 04
Independent Chairman of the Board recently bought €77k worth of stock On the 31st of May, Dale Wolf bought around 13k shares on-market at roughly €5.99 per share. This transaction amounted to 18% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Dale has been a buyer over the last 12 months, purchasing a net total of €62k worth in shares. Reported Earnings • May 10
First quarter 2023 earnings released: US$1.01 loss per share (vs US$1.47 loss in 1Q 2022) First quarter 2023 results: US$1.01 loss per share (improved from US$1.47 loss in 1Q 2022). Revenue: US$73.7m (down 30% from 1Q 2022). Net loss: US$28.0m (loss narrowed 30% from 1Q 2022). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 40 percentage points per year, which is a significant difference in performance. Reported Earnings • Mar 01
Full year 2022 earnings released: US$4.37 loss per share (vs US$4.59 loss in FY 2021) Full year 2022 results: US$4.37 loss per share (improved from US$4.59 loss in FY 2021). Revenue: US$405.4m (down 25% from FY 2021). Net loss: US$119.4m (loss narrowed 2.9% from FY 2021). Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 5.5% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance. Buying Opportunity • Feb 15
Now 22% undervalued Over the last 90 days, the stock is up 171%. The fair value is estimated to be €10.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 1.1% in 2 years. Earnings is forecast to grow by 35% in the next 2 years. Annuncio • Feb 09
eHealth, Inc. Announces Randall Livingston Not Stand for Re-Election to the Board of Directors eHealth, Inc. announced that Randall Livingston will not stand for re-election to the Board of Directors and will step down when his current term expires at the Company’s 2023 annual meeting of shareholders. Annuncio • Feb 07
eHealth, Inc. Welcomes Back Lara Sasken as Senior Vice President, Communications eHealth, Inc. announced the return of Lara Sasken as Senior Vice President of Communications. Prior to that,Lara held senior communications leadership roles at SurveyMonkey, Facebook, and GoPro. Annuncio • Jan 31
eHealth, Inc. to Report Q4, 2022 Results on Feb 28, 2023 eHealth, Inc. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Feb 28, 2023 Annuncio • Jan 24
eHealth, Inc. Appoints Ketan Babaria as SVP and Chief Digital Officer eHealth, Inc. announced the appointment of Ketan Babaria as SVP, Chief Digital Officer. Mr. Babaria joins eHealth from M1 Finance where he served as Chief Product Officer, responsible for defining the company's product vision, strategy, and roadmap to drive growth and profitability. Prior to M1 Finance, Mr. Babaria served as Chief Product Officer at Roofstock, Head of Product at LifeLock, and Sr. Director and Head of Product, D3 Incubation Unit at Capital One. Recent Insider Transactions • Nov 26
CEO & Director recently bought €240k worth of stock On the 22nd of November, Francis Soistman bought around 80k shares on-market at roughly €3.00 per share. This transaction amounted to 23% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Francis' only on-market trade for the last 12 months. Board Change • Nov 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. CEO & Director Fran Soistman was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 09
Third quarter 2022 earnings released: US$1.72 loss per share (vs US$2.24 loss in 3Q 2021) Third quarter 2022 results: US$1.72 loss per share (improved from US$2.24 loss in 3Q 2021). Revenue: US$53.4m (down 17% from 3Q 2021). Net loss: US$47.0m (loss narrowed 22% from 3Q 2021). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 45 percentage points per year, which is a significant difference in performance. Annuncio • Oct 25
eHealth, Inc. to Report Q3, 2022 Results on Nov 07, 2022 eHealth, Inc. announced that they will report Q3, 2022 results on Nov 07, 2022 Annuncio • Oct 11
eHealth, Inc. Appoints Jana Brown as Senior Vice President and Chief People Officer eHealth, Inc. announced the appointment of Jana Brown as SVP, Chief People Officer. Ms. Brown joins eHealth from Centurion Health, an independent subsidiary of Centene, where she served as EVP and Chief Human Resource Officer, responsible for human capital strategy including Talent Acquisition, Talent Management, Employee Relations, Diversity, Equity & Inclusion, Learning & Development, HR Operations, and Total Rewards. Prior to Centurion Health, she served as Head of Talent and Total Rewards at CareSource HealthPlan. She also served as SVP, HR Chief Operating Officer, and Business Partner at TIAA. Annuncio • Sep 09
eHealth Appoints Michelle Barbeau Chief Marketing Officer eHealth, Inc. announced the appointment of Michelle Barbeau as Chief Marketing Officer. Ms. Barbeau is a proven leader with a wealth of experience in the healthcare industry. She comes to eHealth from Ableto, a provider of virtual mental health services, where she led their marketing and communications strategy with a focus on designing experiences that drive loyalty and high ROI. Prior to this, she served four years as a Vice President at UnitedHealthcare, where she transformed a team focused on employer and individual member engagement. She also served eight years in marketing management roles at General Mills. Reported Earnings • Aug 09
Second quarter 2022 earnings released: US$1.65 loss per share (vs US$0.86 loss in 2Q 2021) Second quarter 2022 results: US$1.65 loss per share (down from US$0.86 loss in 2Q 2021). Revenue: US$50.4m (down 48% from 2Q 2021). Net loss: US$45.0m (loss widened 97% from 2Q 2021). Over the next year, revenue is forecast to grow 3.5%, compared to a 26% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance. Annuncio • Jul 28
eHealth, Inc. to Report Q2, 2022 Results on Aug 08, 2022 eHealth, Inc. announced that they will report Q2, 2022 results on Aug 08, 2022 Annuncio • Jun 30
eHealth, Inc. Appoints Gavin Galimi as Senior Vice President, General Counsel and Corporate Secretary eHealth, Inc. announced the appointment of Gavin Galimi as Senior Vice President, General Counsel and Corporate Secretary. Mr. Galimi comes to eHealth with a wealth of experience in the health insurance sector, including 15 years at UnitedHealth Group. He most recently served as General Counsel for UnitedHealthcare Specialty Benefits. In 2017, he co-founded Stratagem Investments, a private equity firm focused on solving society's inequities and disparities in access to good care. He earned his JD at the University of Southern California and his BS in Biological Sciences and BA in International Relations, each from USC. Annuncio • Jun 04
eHealth, Inc. Announces Management Changes On May 31, 2022, eHealth, Inc. appointed John Dolan as chief accounting officer and principal accounting officer of the Company, effective May 31, 2022. Mr. Dolan assumes responsibility as principal accounting officer from Christine Janofsky, who will continue her role as the Company’s chief financial officer and principal financial officer. Mr. Dolan, 54, previously served as deputy controller of The Bank of New York Mellon Corporation, from March 2017 to May 2022. Mr. Dolan also held various senior positions at American Express Company from 2004 to 2017, including most recently as vice president, Americas and global accounting policies controller. Mr. Dolan is a certified public accountant and holds a B.S in accounting from Manhattan College. Reported Earnings • May 04
First quarter 2022 earnings released: US$1.28 loss per share (vs US$0.03 loss in 1Q 2021) First quarter 2022 results: US$1.28 loss per share (down from US$0.03 loss in 1Q 2021). Revenue: US$105.3m (down 22% from 1Q 2021). Net loss: US$35.0m (loss widened US$34.2m from 1Q 2021). Over the next year, revenue is expected to shrink by 7.6% compared to a 20% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 28 percentage points per year, which is a significant difference in performance. Annuncio • May 03
eHealth, Inc., Annual General Meeting, Jun 15, 2022 eHealth, Inc., Annual General Meeting, Jun 15, 2022, at 08:30 Pacific Standard Time. Agenda: To elect the three Class I director nominees to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal; to ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2022; to vote to approve, on an advisory basis, the compensation of Named Executive Officers; to vote to approve an amendment to our Amended and Restated 2014 Equity Incentive Plan to increase the maximum number of shares that may be issued by 3,000,000 shares; and to transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting. Board Change • Apr 27
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Independent Director Randy Livingston is the most experienced director on the board, commencing their role in 2008. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Annuncio • Apr 21
eHealth, Inc. to Report Q1, 2022 Results on May 03, 2022 eHealth, Inc. announced that they will report Q1, 2022 results on May 03, 2022 Recent Insider Transactions • Mar 21
Independent Chairman of the Board recently bought €187k worth of stock On the 14th of March, Dale Wolf bought around 20k shares on-market at roughly €9.36 per share. This was the largest purchase by an insider in the last 3 months. Dale has been a buyer over the last 12 months, purchasing a net total of €1.2m worth in shares. Recent Insider Transactions • Mar 08
Chief Digital Officer recently sold €75k worth of stock On the 4th of March, Phillip Morelock sold around 7k shares on-market at roughly €10.77 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought €2.3m more than they sold in the last 12 months. Annuncio • Mar 04
Ehealth, Inc. Corrects Earnings Guidance for the Full Year Ending December 31, 2022 eHealth, Inc. corrected earnings guidance for the full year ending December 31, 2022. The guidance for GAAP net loss for the full year ending December 31, 2022 in the section titled “2022 Guidance” of the March 1, 2022 press release is corrected as set forth below: --GAAP net loss for the full year ending December 31, 2022 is expected to be in the range of $106.0 million to $83.0 million, corrected from a range of $147.0 million to $124.0 million. Total revenue is expected to be in the range of $448.0 million to $470.0 million. Annuncio • Mar 03
eHealth, Inc. Provides Earnings Guidance for the Full year Ending December 31, 2022 eHealth, Inc. provided earnings guidance for the full year ending December 31, 2022. The company expects total revenue to be in the range of $448.0 million to $470.0 million and GAAP net loss is expected to be in the range of $147.0 million to $124.0 million. Reported Earnings • Mar 02
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Full year 2021 results: US$4.59 loss per share (down from US$1.75 profit in FY 2020). Revenue: US$538.2m (down 7.6% from FY 2020). Net loss: US$122.9m (down 371% from profit in FY 2020). Revenue missed analyst estimates by 1.5%. Over the next year, revenue is forecast to stay flat compared to a 17% growth forecast for the insurance industry in Germany. Annuncio • Mar 01
eHealth Hires Roman Rariy as Chief Operating Officer and Chief Transformation Officer, Effective March 1, 2022 eHealth, Inc. announced that Roman Rariy will join the company as Chief Operating Officer (COO) and Chief Transformation Officer, effective March 1, 2022. In this newrole, Mr. Rariy will mobilize and drive the execution of the organization's value creation plan, manage cost transformation, and bring unwavering focus on operational excellence across the entire organization. Mr. Rariy comes to eHealth from Lionbridge, where he served as Chief Transformation Officer. At Lionbridge he created and directed successful enterprise-wide transformation initiatives focused on the organization and technology operations. Prior to joining Lionbridge, Mr. Rariy served at the Kraft Heinz Company as COO /Head of Operations for Australia and New Zealand, and earlier served in the same capacity for China. Annuncio • Feb 24
Pomerantz Law Firm Notifies Investors of Ehealth, Inc. of a Pending Lawsuit and Lead Plaintiff Deadline of March 18, 2022 Pomerantz LLP notifies investors of eHealth, Inc. of a pending lawsuit against eHealth and certain of its officers. The class action, In re eHealth Inc. Securities Litigation, No. 4:20-cv-02395-JST (the “Class Action”), is pending in the United States District Court for the Northern District of California on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired eHealth common stock between April 26, 2018 and July 23, 2020, inclusive (the “Class” and the “Class Period”). The Class Action pursues claims against the Defendants under the Securities Exchange Act of 1934 (the “Exchange Act”). Annuncio • Feb 09
eHealth, Inc. to Report Q4, 2021 Results on Mar 01, 2022 eHealth, Inc. announced that they will report Q4, 2021 results on Mar 01, 2022 Buying Opportunity • Feb 04
Now 25% undervalued after recent price drop Over the last 90 days, the stock is down 56%. The fair value is estimated to be US$23.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 33% per annum over the last 3 years. The company became loss making over the last year. Annuncio • Feb 01
eHealth, Inc. Announces Executive Changes On January 31, 2022, eHealth, Inc. terminated the employment of the Company’s chief revenue officer, Timothy C. Hannan, and removed him as an officer of the Company and from all of his positions at the Company’s wholly-owned subsidiaries, effective January 31, 2022. The Company has appointed Robert S. Hurley as interim chief revenue officer of the Company effective February 1, 2022. Mr. Hurley previously served as an executive officer of the Company for over 20 years until his retirement in March 2020. Annuncio • Jan 18
Levi & Korsinsky, LLP Notifies Investors of eHealth, Inc. of a Pending Lawsuit and Sets a Lead Plaintiff Deadline of March 18, 2022 Levi & Korsinsky, LLP notified that a class action lawsuit, In re eHealth Inc. Securities Litigation, No. 4:20-cv-02395-JST, is pending in the United States District Court for the Northern District of California. Levi & Korsinsky has been litigating the lawsuit since being appointed as lead counsel on June 24, 2020. The firm has conducted an in-depth investigation, filed an amended complaint, and defeated in part a motion to dismiss. The claims currently pending against eHealth Inc. and the other defendants assert that they materially misrepresented the costs and expenses incurred by the company in connection with the retention of policyholders. The purported class period is April 26, 2018 to July 23, 2020 (both dates inclusive). The prosecution of this litigation has been temporarily stayed pending the appointment of a new lead plaintiff. Any member of the Purported Class may move the Court to serve as lead plaintiff. If you suffered a loss in eHealth, you have until March 18, 2022 to request that the Court appoint you as lead plaintiff. Recent Insider Transactions • Dec 04
Independent Chairman of the Board recently bought €300k worth of stock On the 29th of November, Dale Wolf bought around 15k shares on-market at roughly €19.99 per share. In the last 3 months, they made an even bigger purchase worth €702k. Dale has been a buyer over the last 12 months, purchasing a net total of €1.0m worth in shares. Executive Departure • Dec 03
Chief Accounting Officer & Principal Accounting Officer John Pierantoni has left the company On the 3rd of December, John Pierantoni's tenure as Chief Accounting Officer & Principal Accounting Officer ended after 1.5 years in the role. As of September 2021, John still personally held 1.45k shares (€51k worth at the time). A total of 3 executives have left over the last 12 months. The current median tenure of the management team is 1.50 years, which is considered inexperienced in the Simply Wall St Risk Model. Recent Insider Transactions • Nov 16
Independent Director recently bought €211k worth of stock On the 11th of November, A. Hass bought around 8k shares on-market at roughly €26.40 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €1.3m more in shares than they have sold in the last 12 months. Reported Earnings • Nov 10
Third quarter 2021 earnings released: US$2.24 loss per share (vs US$0.55 loss in 3Q 2020) The company reported a poor third quarter result with increased losses, weaker revenues and weaker control over costs. Third quarter 2021 results: Revenue: US$63.9m (down 32% from 3Q 2020). Net loss: US$59.9m (loss widened 313% from 3Q 2020). Valuation Update With 7 Day Price Move • Nov 09
Investor sentiment deteriorated over the past week After last week's 32% share price decline to €26.17, the stock trades at a trailing P/E ratio of 36.3x. Average forward P/E is 10x in the Insurance industry in Germany. Total loss to shareholders of 56% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €46.05 per share.